VAERS reports by lot

GSK Varicella/Shingles lot 93FR9: VAERS reports

23 VAERS reports list lot 93FR9 as a GSK Varicella/Shingles vaccine, received between 2020-06-21 and 2021-07-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
4%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2532%
Dermatological (non-injection-site)1924%
Injection-site / Local reaction912%
Musculoskeletal810%
Neurological68%
Gastrointestinal45%
Cardiac / Cardiovascular34%
Allergic / Anaphylactic23%
Respiratory11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Georgia6
California3
Florida2
Pennsylvania1
Ohio1
Oregon1
New Hampshire1
Tennessee1
North Carolina1
Vermont1
Nebraska1
South Carolina1

Reports by month received

2020-061
2020-085
2020-095
2020-103
2020-112
2020-122
2021-013
2021-021
2021-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.